Lexaria Bioscience Corp (LEXX) - Margin dodolan resik

Logo grafis Lexaria (LEXX)

Lexaria Bioscience develops advanced drug delivery methods, generating moderate revenue through licensing. The seamless shipment of small compound samples maintains process stability. The aggregate return on sales demonstrates revenue yield, where the -3985.60 metric determines this level. Meanwhile, the business relies on external manufacturers, fully outsourcing tablet production to third-party vendors.

Tingkat bathi resik lexariabioscience.com (LEXX): kanggo periode 04.07.2022 - 19.11.2026

LEXX (Lexaria Bioscience Corp): rincian analitis lan laporan miturut indikator

Ringkesan analitik perusahaan:Lexaria Bioscience - LEXX
Barang unggulan Lexaria Bioscience Corp.

Lexaria Bioscience development of the innovative DehydraTECH platform requires significant investment in clinical trials for obesity and hypertension drugs. Sales margin measures the portion of revenue remaining as net profit after covering all operating expenses and interest payments on debt. This indicator demonstrates the efficiency of intellectual property monetization and resilience to the cost of borrowed capital. Growth in this metric would confirm the successful licensing of technologies by pharmaceutical behemoths. By analyzing the dynamics of net turnover profitability, an investor can assess the issuer's real financial autonomy.

Pesaing langsung

HLN: Margin dodolan resik|Rentabilitas dodolan resik KVUE|Margin resik veronapharma.com|Rentabilitas dodolan resik MENS (Jyong Biotech Corp)|Margin resik Ligand (LGND)|Margin dodolan resik amneal.com (AMRX)|Margin dodolan resik PRGO (perrigo.com)|Alvotech SA (ALVO) - Margin resik|Liquidia Inc. - Margin dodolan resik|Tingkat bathi miturut bathi resik Galapagos Corp (GLPG)|ANI Pharmaceuticals (ANIP) - Margin resik|Rentabilitas dodolan resik MNKD|Margin resik Amphastar Pharmaceuticals, Inc.|Pacira Pharmaceuticals (PCRX) - Margin dodolan perusahaan|Margin dodolan resik SPRY|TBPH - Margin resik|Aquestive Pharma - Rentabilitas dodolan miturut bathi resik|Margin dodolan resik scpharmaceuticals.com SCPH|Tectonic - Margin dodolan resik|TNXP - Margin dodolan resik|SXTC: Margin dodolan resik|Eupraxia Pharma - Tingkat bathi resik|BHST (bioharvest.com) - Margin dodolan resik|Rentabilitas dodolan resik EXOZ (invizyne.com)|Margin dodolan resik ORMP|Margin dodolan perusahaan Entera Bio|Margin dodolan resik HYFT (MindWalk Holdings, Inc.)|ABVC BioPharma - Margin resik|Cumberland Corp - Margin dodolan resik|QNTM - Margin dodolan resik|FibroGen, Inc. (FGEN) - Margin resik|TELO: Rentabilitas resik perusahaan|RANI (Rani Therapeutics Inc) - Margin dodolan resik|Margin resik synergychc.com SNYR|Margin resik Rallybio Corp. (RLYB)|PULM (Pulmatrix, Inc.) - Tingkat bathi resik|Pheton Holdings - Rentabilitas dodolan miturut bathi resik|Margin dodolan resik Aptorum Group Limited APM|LYRA: Rentabilitas dodolan miturut bathi resik|IBO: Margin resik|TNFA: Margin dodolan resik|YCBD: Rentabilitas resik perusahaan|Margin resik PainReform Ltd|CYTO (altamiratherapeutics.com) - Rentabilitas resik perusahaan|Margin dodolan resik LIPO|OPTN - Margin resik|Margin resik pieris.com PIRS|Tingkat bathi resik PROC|PTPI - Margin resik|Qilian International Holding (QLI) - Rentabilitas dodolan miturut bathi resik|SLRN: Margin dodolan resik|Rentabilitas dodolan miturut bathi resik TFF Pharma